Alan Huang
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
Papers in
-
- Cancer-related gene regulation 12
- PI3K/AKT/mTOR signaling in cancer 9
- Melanoma and MAPK Pathways 4
- Oncology 23
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Alan Ashworth (1 shared paper)Barbara L. Weber (1 shared paper)Levi A. Garraway (1 shared paper)William R. Sellers (5 shared papers)Robert Schlegel (14 shared papers)Dejan Juric (3 shared papers)Giordano Caponigro (3 shared papers)Alice Loo (2 shared papers)
- Journals
- Cancer Research (18 papers)Journal of Clinical Oncology (6 papers)Molecular Cancer Therapeutics (5 papers)Cancer Cell (3 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Alan Huang
60 papers receiving 3.3k citations
Alan Huang's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.1k
- Cancer Research 464
- Molecular Biology 2.2k
- Genetics 297
- Pulmonary and Respiratory Medicine 831
Countries citing papers authored by Alan Huang
This map shows the geographic impact of Alan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Huang more than expected).
Fields of papers citing papers by Alan Huang
This network shows the impact of papers produced by Alan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Huang. The network helps show where Alan Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas Hit paper breakdown → | 2012 | 415 |
| 2 | CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors Hit paper breakdown → | 2014 | 357 |
| 3 | 2009 | 309 | |
| 4 | Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study Hit paper breakdown → | 2018 | 309 |
| 5 | 2019 | 307 | |
| 6 | 2018 | 191 | |
| 7 | 2007 | 178 | |
| 8 | 2014 | 144 | |
| 9 | 2020 | 114 | |
| 10 | 2019 | 106 | |
| 11 | 2014 | 97 | |
| 12 | 2013 | 89 | |
| 13 | 2015 | 87 | |
| 14 | 2015 | 60 | |
| 15 | 2013 | 59 | |
| 16 | 2018 | 55 | |
| 17 | 2019 | 55 | |
| 18 | 2013 | 54 | |
| 19 | 2024 | 38 | |
| 20 | 2017 | 34 |
About Alan Huang
Alan Huang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Computational Theory and Mathematics, having authored 65 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related gene regulation (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), HER2/EGFR in Cancer Research (4 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (464 citations), Molecular Biology (2.2k citations), Genetics (297 citations) and Pulmonary and Respiratory Medicine (831 citations). Alan Huang has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Alan Ashworth, Barbara L. Weber, Levi A. Garraway, William R. Sellers, Robert Schlegel, Dejan Juric, Giordano Caponigro, Alice Loo, Hope S. Rugo and Howard A. Burris. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Cancer Cell and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.